Delivery Order SPE2DB20D2014-SPE2DB25FB91X

Award Date 5/12/25
Potential Completion Date 6/3/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 firm fixed-price delivery order is for the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,740.00 Firm Fixed Price Delivery Order contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,370.00, is a Delivery Order for the supply of 4567720736 BRUKINSA 80 MG CAPSULE 120S. It is a Firm Fixed Price contract with an ultimate completion date of April 17, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $12,740.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, over a period ending on May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This federal contract award, valued at $6,370.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4,567,874,470 units of the prescription medication BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of May 1, 2025 and is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,370.00, is for the delivery of BRUKINSA 80 MG CAPSULE 120S. The contract is a firm fixed-price delivery order with an ultimate completion date of April 14, 2025. The award was made on March 24, 2025, and there was no set-aside designation used. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,370.00, is for the delivery of 4567907697 BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of May 5, 2025 and was awarded on April 14, 2025. This appears to be a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 Firm Fixed Price Delivery Order is for the supply of 120 capsules of the medication BRUKINSA 80 MG. The contract has an ultimate completion date of May 28, 2025 and was not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a $6,370.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a medical product, with a period of performance through April 8, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $19,110.00 and a completion date of June 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This contract is not set-aside and is open to full and open competition....
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB91X
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 firm fixed price contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, with a completion date of June 3, 2025. This is a non-set-aside delivery order contract, indicating open competition.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/17/25, 1:15 AM